The effectiveness and value of targeted immune modulators for moderate to severe ulcerative colitis
- DOI
- 10.18553/jmcp.2021.27.3.405
- Published
- 2021-03
- Container
- Journal of Managed Care & Specialty Pharmacy
- Publisher
- Academy of Managed Care Pharmacy
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.18553/jmcp.2021.27.3.405,
title = {The effectiveness and value of targeted immune modulators for moderate to severe ulcerative colitis},
author = {Rajshree Pandey and Daniel A Ollendorf and Katherine Fazioli; and Lisa Bloudek and Josh J Carlson and Steven D Pearson},
year = {2021},
journal = {Journal of Managed Care \& Specialty Pharmacy},
doi = {10.18553/jmcp.2021.27.3.405},
url = {https://doi.org/10.18553/jmcp.2021.27.3.405}
}RIS
TY - JOUR TI - The effectiveness and value of targeted immune modulators for moderate to severe ulcerative colitis AU - Rajshree Pandey AU - Daniel A Ollendorf AU - Katherine Fazioli; AU - Lisa Bloudek AU - Josh J Carlson AU - Steven D Pearson PY - 2021 JO - Journal of Managed Care & Specialty Pharmacy DO - 10.18553/jmcp.2021.27.3.405 UR - https://doi.org/10.18553/jmcp.2021.27.3.405 ER -
APA
Pandey, R., Ollendorf, D. A., Fazioli;, K., Bloudek, L., Carlson, J. J., & Pearson, S. D. (2021). The effectiveness and value of targeted immune modulators for moderate to severe ulcerative colitis. Journal of Managed Care & Specialty Pharmacy. https://doi.org/10.18553/jmcp.2021.27.3.405
Source records
- crossref · retrieved 2026-09-26T03:26:17.856Z